Wald N J, Cuckle H S, Densem J W, Kennard A, Smith D
Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St. Bartholomew's Hospital Medical College, London.
Br J Obstet Gynaecol. 1992 Feb;99(2):144-9. doi: 10.1111/j.1471-0528.1992.tb14474.x.
To investigate the effect of using a routine ultrasound estimate of gestational age and maternal weight adjustment on maternal serum alpha-fetoprotein (AFP), unconjugated oestriol (uE3) and human chorionic gonadotrophin (hCG) levels in antenatal screening for Down's syndrome.
Women with a singleton pregnancy without Down's syndrome were screened using the three serum markers and an estimate of gestational age based on 'dates' (time since first day of the last menstrual period) and one based on an ultrasound scan examination was recorded together with maternal weight.
Women attending the Homerton Hospital, Hackney, for their antenatal care between February 1989 and January 1990.
2113 women with a singleton pregnancy without Down's syndrome.
The use of ultrasound to estimate gestational age (usually based on the biparietal diameter of the fetal skull) led to a significant reduction in the variance of each marker at a given week of pregnancy. The level of each marker was negatively associated with maternal weight, so that adjustment for weight also led to a reduction in variance. These data on gestational age and maternal weight, taken together with published data on pregnancies associated with Down's syndrome, indicate that the routine use of ultrasound to estimate gestational age will increase the detection rate from 58% to 67% while maintaining the false-positive rate at 5%, or reduce the false-positive rate from 5.7% to 3.1% while maintaining the detection rate at 60%. Routine maternal weight adjustment for the serum marker levels was much less useful, increasing the detection rate by about 0.5% for a given false-positive rate, or reducing the false-positive rate about 0.1% for a given detection rate.
An ultrasound gestational age estimate available at the time of Down's syndrome screening confers a substantial advantage to screening performance with a further small benefit resulting from maternal weight adjustment, which is worth adopting if it can be done without difficulty or extra cost.
探讨采用常规超声估计孕周及孕妇体重校正对唐氏综合征产前筛查中孕妇血清甲胎蛋白(AFP)、非结合雌三醇(uE3)和人绒毛膜促性腺激素(hCG)水平的影响。
对单胎妊娠且无唐氏综合征的孕妇进行筛查,采用三种血清标志物,并记录基于“末次月经日期”(自末次月经首日起的时间)估计的孕周以及基于超声扫描检查估计的孕周,同时记录孕妇体重。
1989年2月至1990年1月期间在哈克尼的霍默顿医院接受产前检查的孕妇。
2113名单胎妊娠且无唐氏综合征的孕妇。
采用超声估计孕周(通常基于胎儿颅骨双顶径)可使妊娠特定孕周时各标志物的方差显著降低。各标志物水平与孕妇体重呈负相关,因此校正体重也可使方差降低。这些关于孕周和孕妇体重的数据,结合已发表的与唐氏综合征相关妊娠的数据表明,常规使用超声估计孕周将使检出率从58%提高到67%,同时将假阳性率维持在5%,或者将假阳性率从5.7%降低到3.1%,同时将检出率维持在60%。对血清标志物水平进行常规孕妇体重校正的作用要小得多,在给定假阳性率的情况下,检出率提高约0.5%,或者在给定检出率的情况下,假阳性率降低约0.1%。
在进行唐氏综合征筛查时可获得超声孕周估计对筛查性能有很大优势,孕妇体重校正可带来进一步的微小益处,如果操作不难且无需额外费用,则值得采用。